263 related articles for article (PubMed ID: 36864455)
1. Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
Guo X; Shen R; Yan S; Su Y; Ma L
Cardiovasc Diabetol; 2023 Mar; 22(1):43. PubMed ID: 36864455
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
Tao S; Yu L; Li J; Xie Z; Huang L; Yang D; Tan Y; Zhang W; Huang X; Xue T
Cardiovasc Diabetol; 2023 Nov; 22(1):322. PubMed ID: 38017540
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention.
Chen Q; Xiong S; Zhang Z; Yu X; Chen Y; Ye T; Yang S; Qi L; Chen X; Liu H; Zheng J; Cai L
Cardiovasc Diabetol; 2023 Oct; 22(1):284. PubMed ID: 37865753
[TBL] [Abstract][Full Text] [Related]
4. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
[TBL] [Abstract][Full Text] [Related]
5. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
[TBL] [Abstract][Full Text] [Related]
7. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
[TBL] [Abstract][Full Text] [Related]
8. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
[TBL] [Abstract][Full Text] [Related]
9. The association between the triglyceride-glucose index and in-stent restenosis in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Jiang H; Liu Y; Guo H; Liu Z; Li Z
BMC Cardiovasc Disord; 2024 May; 24(1):234. PubMed ID: 38702615
[TBL] [Abstract][Full Text] [Related]
10. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study.
Cheng Y; Fang Z; Zhang X; Wen Y; Lu J; He S; Xu B
Cardiovasc Diabetol; 2023 Mar; 22(1):75. PubMed ID: 36997935
[TBL] [Abstract][Full Text] [Related]
11. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of the triglyceride-glucose index for cardiovascular events in patients with coronary chronic total occlusion.
Li Y; He S; Wu Z; Li W; Jian W; Cheng Z; Wang C; Shi Y; Liu J
Cardiovasc Diabetol; 2022 Aug; 21(1):149. PubMed ID: 35941586
[TBL] [Abstract][Full Text] [Related]
13. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
[TBL] [Abstract][Full Text] [Related]
14. High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents.
Zhang Y; Chu C; Zhong Z; Luo YB; Ning FF; Guo N
Front Endocrinol (Lausanne); 2023; 14():1101952. PubMed ID: 36875470
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride-glucose index level and variability and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational cohort study.
Wang Y; Wang Y; Sun S; Liu X; Zhao W; Li W; Suo M; Wu Z; Wu X
Lipids Health Dis; 2022 Dec; 21(1):134. PubMed ID: 36482415
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the triglyceride-glucose index for patients with ischemic heart failure after percutaneous coronary intervention.
Sun T; Huang X; Zhang B; Ma M; Chen Z; Zhao Z; Zhou Y
Front Endocrinol (Lausanne); 2023; 14():1100399. PubMed ID: 36814584
[TBL] [Abstract][Full Text] [Related]
17. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
[TBL] [Abstract][Full Text] [Related]
18. The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention.
Yang J; Tang YD; Zheng Y; Li C; Zhou Q; Gao J; Meng X; Zhang K; Wang W; Shao C
Front Endocrinol (Lausanne); 2021; 12():710240. PubMed ID: 34489866
[TBL] [Abstract][Full Text] [Related]
19. Triglyceride-glucose index as a marker of adverse cardiovascular prognosis in patients with coronary heart disease and hypertension.
Liu Y; Zhu B; Zhou W; Du Y; Qi D; Wang C; Cheng Q; Zhang Y; Wang S; Gao C
Cardiovasc Diabetol; 2023 Jun; 22(1):133. PubMed ID: 37296406
[TBL] [Abstract][Full Text] [Related]
20. Association between the triglyceride-glucose index and the presence and prognosis of coronary microvascular dysfunction in patients with chronic coronary syndrome.
Zhang W; Liu L; Chen H; Li S; Wan M; Mohammed AQ; Xu B; Yin G; Lv X; Shi T; Galip J; Mohammed AA; Mareai RM; Xu Y; Abdu FA; Che W
Cardiovasc Diabetol; 2023 May; 22(1):113. PubMed ID: 37179333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
